217 related articles for article (PubMed ID: 36403055)
1. Role of CC-chemokine ligand 2 in gynecological cancer.
Zhang JJ; Liu W; Xing GZ; Xiang L; Zheng WM; Ma ZL
Cancer Cell Int; 2022 Nov; 22(1):361. PubMed ID: 36403055
[TBL] [Abstract][Full Text] [Related]
2. Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women.
Attar R; Agachan B; Kuran SB; Cacina C; Sozen S; Yurdum LM; Attar E; Isbir T
In Vivo; 2010; 24(2):243-8. PubMed ID: 20364004
[TBL] [Abstract][Full Text] [Related]
3. CCL2 in the Tumor Microenvironment.
O'Connor T; Heikenwalder M
Adv Exp Med Biol; 2021; 1302():1-14. PubMed ID: 34286437
[TBL] [Abstract][Full Text] [Related]
4. The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice.
Maus U; von Grote K; Kuziel WA; Mack M; Miller EJ; Cihak J; Stangassinger M; Maus R; Schlöndorff D; Seeger W; Lohmeyer J
Am J Respir Crit Care Med; 2002 Aug; 166(3):268-73. PubMed ID: 12153956
[TBL] [Abstract][Full Text] [Related]
5. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
6. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting.
Xu M; Wang Y; Xia R; Wei Y; Wei X
Cell Prolif; 2021 Oct; 54(10):e13115. PubMed ID: 34464477
[TBL] [Abstract][Full Text] [Related]
7. Role of CCL2/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches.
Moadab F; Khorramdelazad H; Abbasifard M
Life Sci; 2021 Mar; 269():119034. PubMed ID: 33453247
[TBL] [Abstract][Full Text] [Related]
8. A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasis.
Behfar S; Hassanshahi G; Nazari A; Khorramdelazad H
Cytokine; 2018 Oct; 110():226-231. PubMed ID: 29277337
[TBL] [Abstract][Full Text] [Related]
9. CC chemokine receptor 2 is protective against noise-induced hair cell death: studies in CX3CR1(+/GFP) mice.
Sautter NB; Shick EH; Ransohoff RM; Charo IF; Hirose K
J Assoc Res Otolaryngol; 2006 Dec; 7(4):361-72. PubMed ID: 17075702
[TBL] [Abstract][Full Text] [Related]
10. Hyperocclusion up-regulates CCL3 expression in CCL2- and CCR2-deficient mice.
Tsutsumi T; Kajiya H; Goto KT; Takahashi Y; Okabe K
J Dent Res; 2013 Jan; 92(1):65-70. PubMed ID: 23143790
[TBL] [Abstract][Full Text] [Related]
11. Importance of chemokine (CC-motif) ligand 2 in breast cancer.
Steiner JL; Murphy EA
Int J Biol Markers; 2012 Oct; 27(3):e179-85. PubMed ID: 22865298
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity.
Traynor TR; Herring AC; Dorf ME; Kuziel WA; Toews GB; Huffnagle GB
J Immunol; 2002 May; 168(9):4659-66. PubMed ID: 11971015
[TBL] [Abstract][Full Text] [Related]
13. CCL2/CCR2 signaling pathway in glioblastoma multiforme.
Vakilian A; Khorramdelazad H; Heidari P; Sheikh Rezaei Z; Hassanshahi G
Neurochem Int; 2017 Feb; 103():1-7. PubMed ID: 28025034
[TBL] [Abstract][Full Text] [Related]
14. Is the C-C Motif Ligand 2-C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?
Iwamoto H; Izumi K; Mizokami A
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297571
[TBL] [Abstract][Full Text] [Related]
15. The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases.
Zhu S; Liu M; Bennett S; Wang Z; Pfleger KDG; Xu J
J Cell Physiol; 2021 Oct; 236(10):7211-7222. PubMed ID: 33782965
[TBL] [Abstract][Full Text] [Related]
16. CC chemokine ligand 2 and CXC chemokine ligand 8 as neutrophil chemoattractant factors in canine idiopathic polyarthritis.
Murakami K; Maeda S; Yonezawa T; Matsuki N
Vet Immunol Immunopathol; 2016 Dec; 182():52-58. PubMed ID: 27863550
[TBL] [Abstract][Full Text] [Related]
17. CCL2 overexpression is associated with paclitaxel resistance in ovarian cancer cells via autocrine signaling and macrophage recruitment.
Yang YI; Wang YY; Ahn JH; Kim BH; Choi JH
Biomed Pharmacother; 2022 Sep; 153():113474. PubMed ID: 36076499
[TBL] [Abstract][Full Text] [Related]
18. The production of monocyte chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments.
Yoshimura T
Cytokine; 2017 Oct; 98():71-78. PubMed ID: 28189389
[TBL] [Abstract][Full Text] [Related]
19. The inflammatory chemokines CCL2 and CCL5 in breast cancer.
Soria G; Ben-Baruch A
Cancer Lett; 2008 Aug; 267(2):271-85. PubMed ID: 18439751
[TBL] [Abstract][Full Text] [Related]
20. CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation.
Yao M; Fang W; Smart C; Hu Q; Huang S; Alvarez N; Fields P; Cheng N
Mol Cancer Res; 2019 Feb; 17(2):604-617. PubMed ID: 30446625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
